{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:42:49Z","timestamp":1793324569477,"version":"4.5.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20240813150436048"],"award-info":[{"award-number":["JCYJ20240813150436048"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen Medical Research Fund","award":["C2501002"],"award-info":[{"award-number":["C2501002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03349-z","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:34:00Z","timestamp":1788420840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluative performance of triglyceride-glucose-frailty index versus surrogate insulin resistance indices for advanced cardiovascular-kidney-metabolic syndrome, cardiometabolic multimorbidity, and mortality: the role of estimated glomerular filtration rate"],"prefix":"10.1186","volume":"25","author":[{"given":"Kang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hui","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia-Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"3349_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/cir.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148:1606\u201335. https:\/\/doi.org\/10.1161\/cir.0000000000001184.","journal-title":"Circulation"},{"key":"3349_CR2","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1210\/clinem\/dgaf295","volume":"110","author":"N Pohlman","year":"2025","unstructured":"Pohlman N, Patel PN, Essien UR, Tang JJ, Joseph JJ. Novel cardiometabolic medications in the cardiovascular-kidney-metabolic syndrome era. J Clin Endocrinol Metab. 2025;110:2105\u201322. https:\/\/doi.org\/10.1210\/clinem\/dgaf295.","journal-title":"J Clin Endocrinol Metab"},{"key":"3349_CR3","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.cpcardiol.2023.102344","volume":"49","author":"SA Sebastian","year":"2024","unstructured":"Sebastian SA, Padda I, Johal G. Cardiovascular-kidney-metabolic (CKM) syndrome: a state-of-the-art review. Curr Probl Cardiol. 2024;49:102344. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.102344.","journal-title":"Curr Probl Cardiol"},{"key":"3349_CR4","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1001\/jama.2024.6892","volume":"331","author":"R Aggarwal","year":"2011","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011\u20132020. JAMA. 2011;331:1858\u201360. https:\/\/doi.org\/10.1001\/jama.2024.6892.","journal-title":"JAMA"},{"key":"3349_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jacc.2025.05.030","volume":"86","author":"D He","year":"2025","unstructured":"He D, Zhang X, Li C, Yang C, Yu M, Wang J, et al. Rising prevalence of cardiovascular-kidney-metabolic syndrome in China, 2010\u20132019: national cross-sectional surveys. J Am Coll Cardiol. 2025;86:213\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2025.05.030.","journal-title":"J Am Coll Cardiol"},{"key":"3349_CR6","doi-asserted-by":"publisher","first-page":"100985","DOI":"10.1016\/j.ajpc.2025.100985","volume":"22","author":"J Li","year":"2025","unstructured":"Li J, Wei X. Association of cardiovascular-kidney-metabolic syndrome with all-cause and cardiovascular mortality: a prospective cohort study. Am J Prev Cardiol. 2025;22:100985. https:\/\/doi.org\/10.1016\/j.ajpc.2025.100985.","journal-title":"Am J Prev Cardiol"},{"key":"3349_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12933-026-03077-4","volume":"25","author":"T Jin","year":"2026","unstructured":"Jin T, Tang X, Han Y, Fan H, Qin Q, Jiang H, et al. Relationship between nine triglyceride-glucose-related indices and cardiometabolic multimorbidity incidence in patients with cardiovascular-kidney-metabolic syndrome stage 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026;25:36. https:\/\/doi.org\/10.1186\/s12933-026-03077-4.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR8","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.arr.2025.102991","volume":"114","author":"L Yang","year":"2026","unstructured":"Yang L, Zhang Z, Zhang J, Miao J, Zhang H, Du Y, et al. Stage-specific risk factors of cardiometabolic multimorbidity: A systematic review and meta-analysis from incidence to mortality. Ageing Res Rev. 2026;114:102991. https:\/\/doi.org\/10.1016\/j.arr.2025.102991.","journal-title":"Ageing Res Rev"},{"key":"3349_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1186\/s12872-025-05109-5","volume":"25","author":"J Zhang","year":"2015","unstructured":"Zhang J, Tu D. Association between systemic inflammation response index and advanced stages in U.S. cardiovascular-kidney-metabolic syndrome patients: a cross-sectional study using NHANES 2015-2020 data. BMC Cardiovasc Disord. 2015;25:815. https:\/\/doi.org\/10.1186\/s12872-025-05109-5.","journal-title":"BMC Cardiovasc Disord"},{"key":"3349_CR10","doi-asserted-by":"publisher","first-page":"101049","DOI":"10.1016\/j.ajpc.2025.101049","volume":"23","author":"J Liu","year":"2025","unstructured":"Liu J, Gao L, Chen J, Li Z, Zhao W, Qin S, et al. Prevalence and long-term outcomes of NAFLD and cardiovascular-kidney-metabolic health in the United States. Am J Prev Cardiol. 2025;23:101049. https:\/\/doi.org\/10.1016\/j.ajpc.2025.101049.","journal-title":"Am J Prev Cardiol"},{"key":"3349_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.12.015","author":"F Zannad","year":"2026","unstructured":"Zannad F, Khan MS, Bansal N, B\u00f6hm M, Francque SM, Girerd N, et al. MASLD, MASH, and the CKM spectrum: a roadmap for multiorgan clinical trial design. J Am Coll Cardiol. 2026. https:\/\/doi.org\/10.1016\/j.jacc.2025.12.015.","journal-title":"J Am Coll Cardiol"},{"key":"3349_CR12","doi-asserted-by":"publisher","first-page":"e034996","DOI":"10.1161\/jaha.124.034996","volume":"13","author":"J Li","year":"2024","unstructured":"Li J, Lei L, Wang W, Ding W, Yu Y, Pu B, et al. Social risk profile and cardiovascular-kidney-metabolic syndrome in US adults. J Am Heart Assoc. 2024;13:e034996. https:\/\/doi.org\/10.1161\/jaha.124.034996.","journal-title":"J Am Heart Assoc"},{"key":"3349_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1093\/eurheartj\/ehae775","volume":"46","author":"E Braunwald","year":"2025","unstructured":"Braunwald E. From cardiorenal to cardiovascular-kidney-metabolic syndromes. Eur Heart J. 2025;46:682\u20134. https:\/\/doi.org\/10.1093\/eurheartj\/ehae775.","journal-title":"Eur Heart J"},{"key":"3349_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7:216. https:\/\/doi.org\/10.1038\/s41392-022-01073-0.","journal-title":"Signal Transduct Target Ther"},{"key":"3349_CR15","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1161\/circulationaha.105.539528","volume":"112","author":"PW Wilson","year":"2005","unstructured":"Wilson PW, D\u2019Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066\u201372. https:\/\/doi.org\/10.1161\/circulationaha.105.539528.","journal-title":"Circulation"},{"key":"3349_CR16","doi-asserted-by":"publisher","first-page":"111705","DOI":"10.1016\/j.diabres.2024.111705","volume":"212","author":"S Liu","year":"2024","unstructured":"Liu S, Sun H, Liu J, Wang G. Accessing the relationship between six surrogate insulin resistance indexes and the incidence of rapid kidney function decline and the progression to chronic kidney disease among middle-aged and older adults in China: results from the China health and retirement longitudinal study. Diabetes Res Clin Pract. 2024;212:111705. https:\/\/doi.org\/10.1016\/j.diabres.2024.111705.","journal-title":"Diabetes Res Clin Pract"},{"key":"3349_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee SH, Park SY, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46:15\u201337. https:\/\/doi.org\/10.4093\/dmj.2021.0280.","journal-title":"Diabetes Metab J"},{"key":"3349_CR18","doi-asserted-by":"publisher","first-page":"e3502","DOI":"10.1002\/dmrr.3502","volume":"38","author":"JL Silveira Rossi","year":"2022","unstructured":"Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: going beyond traditional risk factors. Diabetes Metab Res Rev. 2022;38:e3502. https:\/\/doi.org\/10.1002\/dmrr.3502.","journal-title":"Diabetes Metab Res Rev"},{"key":"3349_CR19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/s41569-025-01199-y","volume":"22","author":"XD Zhou","year":"2025","unstructured":"Zhou XD, Zheng MH. Cardiovascular-kidney-metabolic syndrome and MASLD: integrating medical perspectives. Nat Rev Cardiol. 2025;22:843. https:\/\/doi.org\/10.1038\/s41569-025-01199-y.","journal-title":"Nat Rev Cardiol"},{"key":"3349_CR20","doi-asserted-by":"publisher","first-page":"102581","DOI":"10.1016\/j.dsx.2022.102581","volume":"16","author":"DL Tahapary","year":"2022","unstructured":"Tahapary DL, Pratisthita LB, Fitri NA, Marcella C, Wafa S, Kurniawan F, et al. Challenges in the diagnosis of insulin resistance: focusing on the role of HOMA-IR and tryglyceride\/glucose index. Diabetes Metab Syndr. 2022;16:102581. https:\/\/doi.org\/10.1016\/j.dsx.2022.102581.","journal-title":"Diabetes Metab Syndr"},{"key":"3349_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12933-025-02662-3","volume":"24","author":"J Hong","year":"2025","unstructured":"Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X. Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:98. https:\/\/doi.org\/10.1186\/s12933-025-02662-3.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank. Cardiovasc Diabetol. 2025;24:277. https:\/\/doi.org\/10.1186\/s12933-025-02842-1.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12933-025-03057-0","volume":"25","author":"Z Li","year":"2026","unstructured":"Li Z, Wu Y, Yang Y, Wang L, Dou S, Sun F, et al. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: evidence from international multi-cohort studies. Cardiovasc Diabetol. 2026;25:42. https:\/\/doi.org\/10.1186\/s12933-025-03057-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24:257. https:\/\/doi.org\/10.1186\/s12933-025-02819-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR25","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12933-023-02054-5","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22:320. https:\/\/doi.org\/10.1186\/s12933-023-02054-5.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR26","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43:61\u20138. https:\/\/doi.org\/10.1093\/ije\/dys203.","journal-title":"Int J Epidemiol"},{"key":"3349_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173:489\u201395. https:\/\/doi.org\/10.1503\/cmaj.050051.","journal-title":"CMAJ"},{"key":"3349_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12933-025-02880-9","volume":"24","author":"YC Zhao","year":"2025","unstructured":"Zhao YC, Wu SQ, Li JK, Sun ZH, Zhang BK, Fu R, et al. Predictive value of the combined triglyceride-glucose and frailty index for cardiovascular disease and stroke in two prospective cohorts. Cardiovasc Diabetol. 2025;24:318. https:\/\/doi.org\/10.1186\/s12933-025-02880-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwaf095","author":"AZZ Phyo","year":"2025","unstructured":"Phyo AZZ, Tonkin A, Espinoza SE, Vishwanath S, Murray AM, Woods RL, et al. Frailty trajectories after a cardiovascular event among community-dwelling older people. Eur J Prev Cardiol. 2025. https:\/\/doi.org\/10.1093\/eurjpc\/zwaf095.","journal-title":"Eur J Prev Cardiol"},{"key":"3349_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s40001-026-03895-y","volume":"31","author":"J Hou","year":"2026","unstructured":"Hou J, Zhao S, Shi J, Zhang Y. Prospective association between the triglyceride-glucose index and frailty in middle-aged and older adults: insights from a nationwide cohort study. Eur J Med Res. 2026;31:118. https:\/\/doi.org\/10.1186\/s40001-026-03895-y.","journal-title":"Eur J Med Res"},{"key":"3349_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jacbts.2020.02.002","volume":"5","author":"AJ Nelson","year":"2020","unstructured":"Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting vascular calcification in chronic kidney disease. JACC Basic Transl Sci. 2020;5:398\u2013412. https:\/\/doi.org\/10.1016\/j.jacbts.2020.02.002.","journal-title":"JACC Basic Transl Sci"},{"key":"3349_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.ajkd.2019.02.013","volume":"74","author":"K Izumaru","year":"2019","unstructured":"Izumaru K, Hata J, Nakano T, Nakashima Y, Nagata M, Fukuhara M, et al. Reduced estimated GFR and cardiac remodeling: a population-based autopsy study. Am J Kidney Dis. 2019;74:373\u201381. https:\/\/doi.org\/10.1053\/j.ajkd.2019.02.013.","journal-title":"Am J Kidney Dis"},{"key":"3349_CR33","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/circulationaha.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski J, Floege J, Fliser D, B\u00f6hm M, Marx N. Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation. 2021;143:1157\u201372. https:\/\/doi.org\/10.1161\/circulationaha.120.050686.","journal-title":"Circulation"},{"key":"3349_CR34","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12933-026-03076-5","volume":"25","author":"Y Wang","year":"2026","unstructured":"Wang Y, Wei N, Li M, Liu JW, Lin HB, Zhang HF. Association between the triglyceride-glucose-frailty index and all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome: the mediating role of the poverty-income ratio. Cardiovasc Diabetol. 2026;25:58. https:\/\/doi.org\/10.1186\/s12933-026-03076-5.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR35","first-page":"1","volume":"2","author":"TM Ezzati","year":"1992","unstructured":"Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: third national health and nutrition examination survey. Vital Health Stat. 1992;2:1\u201335.","journal-title":"Vital Health Stat"},{"key":"3349_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12872-025-04567-1","volume":"25","author":"Z Xu","year":"2025","unstructured":"Xu Z, Wang Y, Li X, Hou X, Yue S, Wang J, et al. Interacting and joint effects of frailty and inflammation on cardiovascular disease risk and the mediating role of inflammation in middle-aged and elderly populations. BMC Cardiovasc Disord. 2025;25:118. https:\/\/doi.org\/10.1186\/s12872-025-04567-1.","journal-title":"BMC Cardiovasc Disord"},{"key":"3349_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-8-24","volume":"8","author":"SD Searle","year":"2008","unstructured":"Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. https:\/\/doi.org\/10.1186\/1471-2318-8-24.","journal-title":"BMC Geriatr"},{"key":"3349_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jamda.2020.07.023","volume":"22","author":"FF Hakeem","year":"2021","unstructured":"Hakeem FF, Bernab\u00e9 E, Sabbah W. Association between oral health and frailty among American older adults. J Am Med Dir Assoc. 2021;22:559-563.e552. https:\/\/doi.org\/10.1016\/j.jamda.2020.07.023.","journal-title":"J Am Med Dir Assoc"},{"key":"3349_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23:134. https:\/\/doi.org\/10.1186\/s12933-024-02215-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR40","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12933-025-02854-x","volume":"24","author":"Y Yue","year":"2025","unstructured":"Yue Y, Li P, Sun Z, Murayama R, Li Z, Hashimoto K, et al. Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24:301. https:\/\/doi.org\/10.1186\/s12933-025-02854-x.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR41","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-025-02576-0","volume":"24","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tu Z, Liu S, Wang J, Shi J, Li X, et al. Association of different insulin resistance surrogates with all-cause and cardiovascular mortality among the population with cardiometabolic multimorbidity. Cardiovasc Diabetol. 2025;24:33. https:\/\/doi.org\/10.1186\/s12933-025-02576-0.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-025-03038-3","volume":"25","author":"X Chen","year":"2025","unstructured":"Chen X, Zhao X, Fei H, Zhang Y, Pang J, Liu Z, et al. Combined association of triglyceride-glucose index and the atherogenic index of plasma with the incidence of cardiovascular diseases among middle-aged and older population. Cardiovasc Diabetol. 2025;25:19. https:\/\/doi.org\/10.1186\/s12933-025-03038-3.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR43","doi-asserted-by":"publisher","first-page":"101419","DOI":"10.1016\/j.jhepr.2025.101419","volume":"7","author":"K Song","year":"2025","unstructured":"Song K, Lee E, Lee HS, Youn YH, Baik SJ, Shin HJ, et al. Identification of pediatric MASLD using insulin resistance indices. JHEP Rep. 2025;7:101419. https:\/\/doi.org\/10.1016\/j.jhepr.2025.101419.","journal-title":"JHEP Rep"},{"key":"3349_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jamaoto.2021.0057","volume":"147","author":"C Cao","year":"2021","unstructured":"Cao C, Cade WT, Li S, McMillan J, Friedenreich C, Yang L. Association of balance function with all-cause and cause-specific mortality among US adults. JAMA Otolaryngol Head Neck Surg. 2021;147:460\u20138. https:\/\/doi.org\/10.1001\/jamaoto.2021.0057.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"3349_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12933-024-02172-8","volume":"23","author":"L Ding","year":"2005","unstructured":"Ding L, Zhang H, Dai C, Zhang A, Yu F, Mi L, et al. The prognostic value of the stress hyperglycemia ratio for all-cause and cardiovascular mortality in patients with diabetes or prediabetes: insights from NHANES 2005-2018. Cardiovasc Diabetol. 2005;23:84. https:\/\/doi.org\/10.1186\/s12933-024-02172-8.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/jdi.14367","volume":"16","author":"Y Feng","year":"2025","unstructured":"Feng Y, Jin X, Zhu J, Yuan M, Zhu L, Ye D, et al. Association between endogenous estradiol, testosterone, and long-term mortality in adults with prediabetes and diabetes: evidence from NHANES database. J Diabetes Investig. 2025;16:481\u201391. https:\/\/doi.org\/10.1111\/jdi.14367.","journal-title":"J Diabetes Investig"},{"key":"3349_CR47","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s12877-024-04992-5","volume":"24","author":"L Ding","year":"2007","unstructured":"Ding L, Fu B, Zhang H, Dai C, Zhang A, Yu F, et al. The impact of triglyceride glucose-body mass index on all-cause and cardiovascular mortality in elderly patients with diabetes mellitus: evidence from NHANES 2007\u20132016. BMC Geriatr. 2007;24:356. https:\/\/doi.org\/10.1186\/s12877-024-04992-5.","journal-title":"BMC Geriatr"},{"key":"3349_CR48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.7326\/annals-24-01321","volume":"178","author":"JB Sussman","year":"2025","unstructured":"Sussman JB, Wilson LM, Burke JF, Ziaeian B, Anderson TS. Clinical characteristics and current management of U.S. adults at elevated risk for heart failure using the PREVENT equations: a cross-sectional analysis. Ann Intern Med. 2025;178:144\u20137. https:\/\/doi.org\/10.7326\/annals-24-01321.","journal-title":"Ann Intern Med"},{"key":"3349_CR49","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","journal-title":"N Engl J Med"},{"key":"3349_CR50","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1001\/jama.2023.22276","volume":"330","author":"H Larkin","year":"2023","unstructured":"Larkin H. Here\u2019s what to know about cardiovascular-kidney-metabolic syndrome. Newly Defined by the AHA Jama. 2023;330:2042\u20133. https:\/\/doi.org\/10.1001\/jama.2023.22276.","journal-title":"Newly Defined by the AHA Jama"},{"key":"3349_CR51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jacasi.2024.12.003","volume":"5","author":"H Zhang","year":"2025","unstructured":"Zhang H, Hu Z, Wu J, Li Y, Jiang S, Jin L, et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages among middle-aged and older adults in China. JACC Asia. 2025;5:393\u20135. https:\/\/doi.org\/10.1016\/j.jacasi.2024.12.003.","journal-title":"JACC Asia"},{"key":"3349_CR52","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12933-025-02742-4","volume":"24","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Cao Z, Teng J, Lu Q, Huang P, Zhou J. Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24:183. https:\/\/doi.org\/10.1186\/s12933-025-02742-4.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/eurheartj\/ehac744","volume":"44","author":"A Dove","year":"2023","unstructured":"Dove A, Guo J, Marseglia A, Fastbom J, Vetrano DL, Fratiglioni L, et al. Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry. Eur Heart J. 2023;44:573\u201382. https:\/\/doi.org\/10.1093\/eurheartj\/ehac744.","journal-title":"Eur Heart J"},{"key":"3349_CR54","doi-asserted-by":"publisher","first-page":"1591799","DOI":"10.3389\/fnut.2025.1591799","volume":"12","author":"S Hu","year":"2025","unstructured":"Hu S, Song J, Jiang H, Wei B, Wang H. Association between the dietary index for gut microbiota and cardiometabolic multimorbidity: systemic immune-inflammation index and systemic inflammatory response index. Front Nutr. 2025;12:1591799. https:\/\/doi.org\/10.3389\/fnut.2025.1591799.","journal-title":"Front Nutr"},{"key":"3349_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03109-z","author":"Y Lin","year":"2026","unstructured":"Lin Y, Tao J, Wang H, Guan H, Liu X, Dong X, et al. The association of C-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03109-z.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study. Cardiovasc Diabetol. 2025;24:92. https:\/\/doi.org\/10.1186\/s12933-025-02642-7.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR57","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12933-023-02002-3","volume":"22","author":"Y Yuan","year":"2023","unstructured":"Yuan Y, Chen S, Lin C, Huang X, Lin S, Huang F, et al. Association of triglyceride-glucose index trajectory and frailty in urban older residents: evidence from the 10-year follow-up in a cohort study. Cardiovasc Diabetol. 2023;22:264. https:\/\/doi.org\/10.1186\/s12933-023-02002-3.","journal-title":"Cardiovasc Diabetol"},{"key":"3349_CR58","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cmet.2024.03.012","volume":"36","author":"M Mishra","year":"2024","unstructured":"Mishra M, Wu J, Kane AE, Howlett SE. The intersection of frailty and metabolism. Cell Metab. 2024;36:893\u2013911. https:\/\/doi.org\/10.1016\/j.cmet.2024.03.012.","journal-title":"Cell Metab"},{"key":"3349_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.93312","author":"T Gicquel","year":"2024","unstructured":"Gicquel T, Marchiano F, Reyes-Castellanos G, Audebert S, Camoin L, Habermann BH, et al. Integrative study of skeletal muscle mitochondrial dysfunction in a murine pancreatic cancer-induced cachexia model. Elife. 2024. https:\/\/doi.org\/10.7554\/eLife.93312.","journal-title":"Elife"},{"key":"3349_CR60","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00394-025-03653-6","volume":"64","author":"AP Almeida","year":"2025","unstructured":"Almeida AP, Lopes LJ, Bersch-Ferreira \u00c2C, Torreglosa CR, Marcadenti A, Weber B, et al. Insulin resistance mediate the association between leucine intake, dietary glycemic index, and type 2 diabetes in secondary cardiovascular prevention: path analysis from Brazilian cardioprotective nutritional (BALANCE) program. Eur J Nutr. 2025;64:140. https:\/\/doi.org\/10.1007\/s00394-025-03653-6.","journal-title":"Eur J Nutr"},{"key":"3349_CR61","doi-asserted-by":"publisher","first-page":"e13729","DOI":"10.1002\/jcsm.13729","volume":"16","author":"A V\u00e1zquez-Fern\u00e1ndez","year":"2025","unstructured":"V\u00e1zquez-Fern\u00e1ndez A, Caballero FF, Y\u00e9venes-Briones H, Struijk EA, Baylin A, Fung TT, et al. Plant and animal protein intake and transitions from multimorbidity to frailty and mortality in older adults. J Cachexia Sarcopenia Muscle. 2025;16:e13729. https:\/\/doi.org\/10.1002\/jcsm.13729.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3349_CR62","doi-asserted-by":"publisher","first-page":"36205","DOI":"10.31083\/rcm36205","volume":"26","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Xu D, Zheng W, Hao W, Zhen L, Yan Y, et al. Impact of obstructive sleep apnea and triglyceride glucose index on cardiovascular events in acute coronary syndrome patients: a post-hoc analysis of the OSA-ACS study. Rev Cardiovasc Med. 2025;26:36205. https:\/\/doi.org\/10.31083\/rcm36205.","journal-title":"Rev Cardiovasc Med"},{"key":"3349_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cells14050340","author":"H Ota","year":"2025","unstructured":"Ota H, Ohnuma T, Kodama A, Shimizu T, Sugawara K, Yamamoto F. The cholinergic receptor nicotinic \u03b13 was reduced in the hippocampus of early cognitively impaired adult male mice and upregulated by nicotine and cytisine in HT22 cells. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14050340.","journal-title":"Cells"},{"key":"3349_CR64","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.m146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56:M146-156. https:\/\/doi.org\/10.1093\/gerona\/56.3.m146.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"3349_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13092686","author":"H Calila","year":"2024","unstructured":"Calila H, B\u0103l\u0103\u0219escu E, Nedelcu RI, Ion DA. Endothelial dysfunction as a key link between cardiovascular disease and frailty: a systematic review. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13092686.","journal-title":"J Clin Med"},{"key":"3349_CR66","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7326\/m20-0864","volume":"173","author":"A Tsapas","year":"2020","unstructured":"Tsapas A, Avgerinos I, Karagiannis T, Malandris K, Manolopoulos A, Andreadis P, et al. Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis. Ann Intern Med. 2020;173:278\u201386. https:\/\/doi.org\/10.7326\/m20-0864.","journal-title":"Ann Intern Med"},{"key":"3349_CR67","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.mayocp.2025.01.018","volume":"100","author":"M Banach","year":"2025","unstructured":"Banach M, Jaiswal V, Ang SP, Sawhney A, Deb N, Amarenco P, et al. Impact of lipid-lowering combination therapy with statins and ezetimibe vs statin monotherapy on the reduction of cardiovascular outcomes: a meta-analysis. Mayo Clin Proc. 2025;100:2152\u201371. https:\/\/doi.org\/10.1016\/j.mayocp.2025.01.018.","journal-title":"Mayo Clin Proc"},{"key":"3349_CR68","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrneph.2016.145","volume":"12","author":"F Artunc","year":"2016","unstructured":"Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, H\u00e4ring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016;12:721\u201337. https:\/\/doi.org\/10.1038\/nrneph.2016.145.","journal-title":"Nat Rev Nephrol"},{"key":"3349_CR69","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.cjca.2020.02.066","volume":"36","author":"AA da Silva","year":"2020","unstructured":"da Silva AA, do Carmo JM, Li X, Wang Z, Mouton AJ, Hall JE. Role of hyperinsulinemia and insulin resistance in hypertension: metabolic syndrome revisited. Can J Cardiol. 2020;36:671\u201382. https:\/\/doi.org\/10.1016\/j.cjca.2020.02.066.","journal-title":"Can J Cardiol"},{"key":"3349_CR70","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1093\/ndt\/gfaa323","volume":"36","author":"M Wang","year":"2021","unstructured":"Wang M, Sun X, Zhang W, Zhang Q, Qian J, Chen W, et al. Frailty and the risk of kidney function decline in the elderly population: the Rugao Longevity and Ageing Study. Nephrol Dial Transplant. 2021;36:2274\u201381. https:\/\/doi.org\/10.1093\/ndt\/gfaa323.","journal-title":"Nephrol Dial Transplant"},{"key":"3349_CR71","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2147\/cia.S409140","volume":"18","author":"X Shi","year":"2023","unstructured":"Shi X, Wang S, Hu J, Chen F, Zhang H, Yang Y, et al. Relationship of frailty with kidney function in adults more than 60-years-old: effect of using different formulas to estimate glomerular filtration rate. Clin Interv Aging. 2023;18:999\u20131007. https:\/\/doi.org\/10.2147\/cia.S409140.","journal-title":"Clin Interv Aging"},{"key":"3349_CR72","doi-asserted-by":"publisher","first-page":"2577839","DOI":"10.1080\/0886022x.2025.2577839","volume":"47","author":"Y Deng","year":"2025","unstructured":"Deng Y, Cheng C, Kang J, Guo X, Li S, Liang H, et al. Baseline and long-term frailty transitions and rapid estimated glomerular filtration rate decline: evidence from two large population-based studies. Ren Fail. 2025;47:2577839. https:\/\/doi.org\/10.1080\/0886022x.2025.2577839.","journal-title":"Ren Fail"},{"key":"3349_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/nu11092090","author":"T Senoner","year":"2019","unstructured":"Senoner T, Dichtl W. Oxidative stress in cardiovascular diseases: still a therapeutic target? Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11092090.","journal-title":"Nutrients"},{"key":"3349_CR74","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2013.02.005","volume":"378","author":"R Nistala","year":"2013","unstructured":"Nistala R, Whaley-Connell A. Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II. Mol Cell Endocrinol. 2013;378:53\u20138. https:\/\/doi.org\/10.1016\/j.mce.2013.02.005.","journal-title":"Mol Cell Endocrinol"},{"key":"3349_CR75","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12964-022-01016-w","volume":"21","author":"C Xue","year":"2023","unstructured":"Xue C, Chen K, Gao Z, Bao T, Dong L, Zhao L, et al. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction. Cell Commun Signal. 2023;21:298. https:\/\/doi.org\/10.1186\/s12964-022-01016-w.","journal-title":"Cell Commun Signal"},{"key":"3349_CR76","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/ajh\/hpaa053","volume":"33","author":"T Matsumoto","year":"2020","unstructured":"Matsumoto T, Kojima M, Takayanagi K, Taguchi K, Kobayashi T. Role of S-equol, indoxyl sulfate, and trimethylamine N-oxide on vascular function. Am J Hypertens. 2020;33:793\u2013803. https:\/\/doi.org\/10.1093\/ajh\/hpaa053.","journal-title":"Am J Hypertens"},{"key":"3349_CR77","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1161\/cir.0000000000000920","volume":"142","author":"J Rangaswami","year":"2020","unstructured":"Rangaswami J, Bhalla V, de Boer IH, Staruschenko A, Sharp JA, Singh RR, et al. Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: a scientific statement from the American Heart Association. Circulation. 2020;142:e265\u201386. https:\/\/doi.org\/10.1161\/cir.0000000000000920.","journal-title":"Circulation"},{"key":"3349_CR78","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","volume":"43","author":"R Agarwal","year":"2022","unstructured":"Agarwal R, Filippatos G, Pitt B, Anker SD, Rossing P, Joseph A, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474\u201384. https:\/\/doi.org\/10.1093\/eurheartj\/ehab777.","journal-title":"Eur Heart J"},{"key":"3349_CR79","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/s0140-6736(11)60739-3","volume":"377","author":"C Baigent","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011;377:2181\u201392. https:\/\/doi.org\/10.1016\/s0140-6736(11)60739-3.","journal-title":"Lancet"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03349-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:21:59Z","timestamp":1788430919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03349-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3349"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03349-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The NHANES protocol was approved by the Institutional Review Board of the National Center for Health Statistics (\n                      \n                      ). All participants provided written informed consent.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"267"}}